Life Science Investing Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
Life Science Investing Galectin Therapeutics to Present at the American Association for the Study of Liver Disease Liver Meeting 2025
Life Science Investing Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update
Significant Gold Discoveries Continue at Golden Gate - Drilling Hits 253.0m @ 1.5 g/t Au from Surface and Open in all Directions Ending in Mineralisation
Detailed Ground Gravity, Magnetic and Radiometric Surveys Refine Priority REE Targets at Desert Star Projects, California, USA
